Santo Domingo, RD.
The various agreements the Dominican government has made with pharmaceutical companies responsible for developing vaccines against the covid-19 pandemic will give the country access to 20 million doses, according to the state.
The amounts are distributed as follows: 10 million doses with Astrazeneca, 8 million with Pfizer-BioNTech and 2 million with Covax, the latter a global mechanism of the World Health Organization (WHO) to ensure worldwide access to vaccinations.
Last Friday, October 30, the Dominican government signed an agreement with British biopharmaceutical company AstraZeneca to acquire 10 million doses of its AZD1222 vaccine, co-developed with the University of Oxford.
The total investment is $ 40 million, four dollars per vaccine. The first $ 8 million payment will be made by the private sector.
While on January 15, the vice president of the republic, Raquel Peña, reported that the government had entered into an agreement with pharmaceutical companies Pfizer and BioNTech, guaranteeing 7.9 million doses of the BNT162b2 vaccine against Covid-19.
According to Luis Abinader’s government, these doses will be defined by phases ranging from the “characteristics of the prioritized risk groups, the volume and periodicity of the vaccine supply, the positioning and promotion of vaccination in the population. Important aspects”.
Likewise, the government reported that it expects 7,101,043 people between the ages of 18 and 80 to have received the dose by December this year, “depending on the supply situations that develop during the health emergency.”
The phases will be defined based on the characteristics of the prioritized risk groups, the volume and periodicity of the vaccine supply, the positioning and promotion of vaccination in the population, among other important aspects. pic.twitter.com/mVB3ndlRwJ
– CommunicationsRD (@Comunicaciondo) January 22, 2021